Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

18,447 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Transforming growth factorβ1 L10P variant plays an active role on the breast cancer susceptibility in Caucasian: evidence from 10,392 cases and 11,697 controls.
Ma X, Chen C, Xiong H, Li Y. Ma X, et al. Breast Cancer Res Treat. 2010 Nov;124(2):453-7. doi: 10.1007/s10549-010-0843-x. Epub 2010 Mar 27. Breast Cancer Res Treat. 2010. PMID: 20349130 Review.
[Development of a model for the diagnosis and risk classification on anthrax through artificial neural network].
Han JX, Xiong HY, Zhang TH, Xu B, Li YF, Zhu CZ, Ma XY, Zhang L. Han JX, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Oct;27(10):875-9. Zhonghua Liu Xing Bing Xue Za Zhi. 2006. PMID: 17343182 Chinese.
Through 500 times training on the neural network, the performance error decreased from 6.669 59 to 5.051 19 x 10(-11). The model was then validated. ...
Through 500 times training on the neural network, the performance error decreased from 6.669 59 to 5.051 19 x 10(-11). The model was …
No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls.
Ma X, Chen C, Xiong H, Fan J, Li Y, Lin H, Xu R, Huang G, Xu B. Ma X, et al. Breast Cancer Res Treat. 2010 Jul;122(2):509-14. doi: 10.1007/s10549-009-0725-2. Epub 2010 Jan 6. Breast Cancer Res Treat. 2010. PMID: 20052533 Review.
Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls.
Ma X, Qi X, Chen C, Lin H, Xiong H, Li Y, Jiang J. Ma X, et al. Breast Cancer Res Treat. 2010 Jul;122(2):495-501. doi: 10.1007/s10549-009-0693-6. Epub 2010 Jan 6. Breast Cancer Res Treat. 2010. PMID: 20052540 Review.
Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J. Qi X, et al. Breast Cancer Res Treat. 2010 Sep;123(2):499-506. doi: 10.1007/s10549-010-0773-7. Epub 2010 Feb 5. Breast Cancer Res Treat. 2010. PMID: 20135343
Extremely low-frequency electromagnetic fields exposure and female breast cancer risk: a meta-analysis based on 24,338 cases and 60,628 controls.
Chen C, Ma X, Zhong M, Yu Z. Chen C, et al. Breast Cancer Res Treat. 2010 Sep;123(2):569-76. doi: 10.1007/s10549-010-0782-6. Epub 2010 Feb 10. Breast Cancer Res Treat. 2010. PMID: 20145992
Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians.
Ma X, Beeghly-Fadiel A, Lu W, Shi J, Xiang YB, Cai Q, Shen H, Shen CY, Ren Z, Matsuo K, Khoo US, Iwasaki M, Long J, Zhang B, Ji BT, Zheng Y, Wang W, Hu Z, Liu Y, Wu PE, Shieh YL, Wang S, Xie X, Ito H, Kasuga Y, Chan KY, Iwata H, Tsugane S, Gao YT, Shu XO, Moses HL, Zheng W. Ma X, et al. Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1176-84. doi: 10.1158/1055-9965.EPI-12-0118. Epub 2012 Apr 26. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22539603 Free PMC article.
No association between ovarian cancer susceptibility variants and breast cancer risk among Chinese women.
Ma X, Cai Q, Delahanty RJ, Shu XO, Zhang B, Lu W, Gao YT, Zheng W, Long J, Beeghly-Fadiel A. Ma X, et al. Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):467-9. doi: 10.1158/1055-9965.EPI-12-1365. Epub 2013 Jan 4. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23292081 Free PMC article.
18,447 results
Jump to page
Feedback